Maglangit, Jay Lorenz G.
HRN: 10-81-72 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2023
CEFUROXIME 1.5GM (VIAL)
06/25/2023
07/01/2023
IVTT
980mg
Q8h
Dengue Fever With WS, BA Not In AE
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes